Recently, Xingwang Shiyi, a subsidiary of Sunway Ruijie, announced its official entry into the brain-computer therapeutic market, marking a strategic expansion by the company—long known for network communications and digital entertainment solutions—into the health-tech sector. Leveraging Sunway Ruijie’s expertise in smart hardware, human-computer interaction, and edge computing, Xingwang Shiyi is developing brain-computer interface (BCI) products that integrate EEG sensing, neurofeedback, and AI algorithms to address mental wellness, attention training, and sleep improvement. Its first therapeutic device is already in clinical trials, utilizing non-invasive brainwave monitoring and personalized feedback to help users reduce anxiety, enhance focus, and improve sleep quality. This move reflects Sunway Ruijie’s strategic alignment with the convergence of technology and healthcare, as well as the broader trend of Chinese tech firms accelerating the consumer application of brain science. Going forward, Xingwang Shiyi plans to collaborate with medical institutions and research organizations to build an integrated BCI therapeutic ecosystem and promote the standardization and accessibility of digital therapeutics.
近日，星网锐捷旗下子公司星网视易宣布正式进军脑机疗愈领域，标志着这家以网络通信和数字娱乐解决方案闻名的企业开始向大健康科技赛道拓展。星网视易将依托母公司在智能硬件、人机交互及边缘计算方面的技术积累，结合脑电（EEG）传感、神经反馈与人工智能算法，开发面向心理健康干预、注意力训练及睡眠改善等场景的脑机接口（BCI）产品。据悉，其首款疗愈设备已进入临床测试阶段，旨在通过非侵入式脑波监测与个性化反馈机制，帮助用户缓解焦虑、提升专注力并优化睡眠质量。此举不仅体现了星网锐捷对‘科技+健康’融合趋势的战略布局，也反映了国内科技企业正加速探索脑科学在消费级市场的应用落地。未来，星网视易计划联合医疗机构、科研院所共建脑机疗愈生态，推动数字疗法标准化与普及化。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/11353.html